
Join to View Full Profile
631 Professional DrSte 210Lawrenceville, GA 30046
Phone+1 678-312-3235
Fax+1 678-312-2020
Dr. Hagenstad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2003
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1998 - 2001
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1998
Certifications & Licensure
GA State Medical License 2003 - 2027
NC State Medical License 2001 - 2004
VA State Medical License 1998 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2013
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012
Clinical Trials
Publications & Presentations
PubMed
- 442 citationsDurvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 studyAtlantic Investigators
The Lancet. Oncology. 2018-04-01 - 3 citationsCardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects wi...Sara A. Hurvitz, Linda D. Bosserman, David Chan, Christopher T Hagenstad, Frederick C Kass
Springerplus. 2014-05-12 - 85 citationsRandomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal CancerJohanna C. Bendell, John Nemunaitis, Sasha Vukelja, Christopher Hagenstad, Luis T. Campos
Journal of Clinical Oncology. 2011-11-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









